1. Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study. (December 2018) Authors: Koga, Takamasa; Kobayashi, Yoshihisa; Tomizawa, Kenji; Suda, Kenichi; Kosaka, Takayuki; Sesumi, Yuichi; Fujino, Toshio; Nishino, Masaya; Ohara, Shuta; Chiba, Masato; Shimoji, Masaki; Takemoto, Toshiki; Suzuki, Makoto; Jänne, Pasi A.; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 126(2018) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancer. (October 2017) Authors: Tomizawa, Kenji; Shimizu, Shigeki; Ohara, Shuta; Fujino, Toshio; Nishino, Masaya; Sesumi, Yuichi; Kobayashi, Yoshihisa; Sato, Katsuaki; Chiba, Masato; Shimoji, Masaki; Suda, Kenichi; Takemoto, Toshiki; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 112(2017) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine. (15th December 2017) Authors: Takahashi, Koichi; Yoshisue, Kunihiro; Chiba, Masato; Nakanishi, Takeo; Tamai, Ikumi Journal: Biopharmaceutics & drug disposition Issue: Volume 39:Number 1(2018:Jan.) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development of Caco-2 cells co-expressing CYP3A4 and NADPH-cytochrome P450 reductase using a human artificial chromosome for the prediction of intestinal extraction ratio of CYP3A4 substrates. Issue 1 (February 2017) Authors: Takenaka, Toru; Kazuki, Kanako; Harada, Naomoto; Kuze, Jiro; Chiba, Masato; Iwao, Takahiro; Matsunaga, Tamihide; Abe, Satoshi; Oshimura, Mitsuo; Kazuki, Yasuhiro Journal: Drug metabolism and pharmacokinetics Issue: Volume 32:Issue 1(2017) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancer. (April 2021) Authors: Ohara, Shuta; Suda, Kenichi; Fujino, Toshio; Hamada, Akira; Koga, Takamasa; Nishino, Masaya; Chiba, Masato; Shimoji, Masaki; Takemoto, Toshiki; Soh, Junichi; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 154(2021) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells. (February 2017) Authors: Sesumi, Yuichi; Suda, Kenichi; Mizuuchi, Hiroshi; Kobayashi, Yoshihisa; Sato, Katsuaki; Chiba, Masato; Shimoji, Masaki; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 104(2017) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro. (December 2018) Authors: Nishino, Masaya; Suda, Kenichi; Kobayashi, Yoshihisa; Ohara, Shuta; Fujino, Toshio; Koga, Takamasa; Chiba, Masato; Shimoji, Masaki; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 126(2018) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trial. (December 2021) Authors: Hamada, Akira; Suda, Kenichi; Koga, Takamasa; Fujino, Toshio; Nishino, Masaya; Ohara, Shuta; Chiba, Masato; Shimoji, Masaki; Takemoto, Toshiki; Soh, Junichi; Uchida, Tetsuro; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 162(2021) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluridine Using Human Small Intestinal Epithelial Cells. Issue 9 (21st April 2015) Authors: Takahashi, Koichi; Yoshisue, Kunihiro; Chiba, Masato; Nakanishi, Takeo; Tamai, Ikumi; Donovan, Maureen D.; Langguth, Peter; Polli, James E.; Tamai, Ikumi; Vig, Balvinder; Yu, Lawrence X. Journal: Journal of pharmaceutical sciences Issue: Volume 104:Issue 9(2015:Sep.) Page Start: 3146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor in lung cancer. Issue 4 (28th March 2016) Authors: Mizuuchi, Hiroshi; Suda, Kenichi; Murakami, Isao; Sakai, Kazuko; Sato, Katsuaki; Kobayashi, Yoshihisa; Shimoji, Masaki; Chiba, Masato; Sesumi, Yuichi; Tomizawa, Kenji; Takemoto, Toshiki; Sekido, Yoshitaka; Nishio, Kazuto; Mitsudomi, Tetsuya Journal: Cancer science Issue: Volume 107:Issue 4(2016) Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗